7 min read · May 2026
5 Red Flags When Choosing a Compounding Pharmacy in 2026
Context: The FDA has issued over 50 warning letters to compounders and telehealth distributors since early 2025. Not all compounding pharmacies are equal. Here are the five signs you're working with the wrong one.
The compounded GLP-1 market ranges from rigorously legitimate pharmacies with PCAB accreditation and USP 797 compliance to operations that popped up in 2024 with minimal oversight. Your health depends on knowing the difference.
Red Flag #1: No Pharmacy Identification
Legitimate telehealth platforms disclose which pharmacy fills your prescription. If a provider won't tell you the name and license number of their pharmacy partner, walk away. Every state-licensed pharmacy has a searchable license through the respective state Board of Pharmacy. You should be able to verify it in two minutes.
Red Flag #2: Prices That Seem Impossibly Low
Compounded semaglutide has real production costs: pharmaceutical-grade API, sterility testing, beyond-use dating studies, licensed pharmacist oversight, cold-chain shipping. When someone offers compounded semaglutide at $49/month, ask yourself what they're cutting to hit that number. Quality testing? Sterility assurance? Proper API sourcing?
The current market floor for legitimately compounded semaglutide from vetted pharmacies is approximately $147/month. Anything substantially below that warrants scrutiny.
Red Flag #3: No Beyond-Use Date (BUD) on Your Vial
Every compounded medication must have a beyond-use date — the date after which potency and sterility cannot be guaranteed. If your vial arrives without a clearly printed BUD, your pharmacy isn't following USP 797 guidelines. This is a basic compliance requirement, not an optional label.
Red Flag #4: They Advertise "FDA-Approved Compounded Semaglutide"
This phrase is a contradiction in terms. Compounded medications are, by definition, not FDA-approved. Any provider or pharmacy using this language is either incompetent (doesn't understand the regulatory framework they operate in) or deliberately misleading patients. Neither is acceptable.
Red Flag #5: No Clinical Evaluation Before Prescribing
A legitimate GLP-1 prescriber will evaluate your medical history, current medications, BMI, contraindications (eating disorders, medullary thyroid carcinoma history, pancreatitis), and establish a titration schedule. If you receive a prescription without answering detailed health questions — or if the "consultation" is a two-question form that takes 30 seconds — the prescribing practice doesn't meet medical standards.
What Good Looks Like
Embody
Physician-supervised protocols with established pharmacy partners. Transparent supply chain.
Compounded medications are not FDA-approved.
Learn More Paid linkCare Bare Rx
Licensed physicians conduct thorough intake evaluations. Ongoing monitoring included.
Compounded medications are not FDA-approved.
Learn More Paid linkOak Weight Loss
GLP-1 specific landing page with detailed pharmacy and provider credentials.
Compounded medications are not FDA-approved.
Learn More Paid linkCompare GLP-1 Providers Side by Side
See pricing, medications, and ratings for verified telehealth providers.
View Provider Comparison →Sources
- FDA. Warning letters database: compounding pharmacies, 2025-2026.
- USP. Chapter 797: Pharmaceutical Compounding — Sterile Preparations.
- PCAB. Accreditation standards for compounding pharmacies.
- FDA. Adverse event reports: compounded semaglutide (455+) and tirzepatide (320+).
Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
FDA Notice: Compounded medications referenced in this article are not FDA-approved. Only brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro) carry FDA approval for their indicated uses.